Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam XR add-on therapy in refractory partial-onset seizures
2006-000987-10Phase 3Completed
- Sponsor
- UCB
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Levetiracetam XR add-on with Placebo add-on (2 arms). Primary endpoints: Efficacy in reducing partial-onset seizures (LEV XR vs placebo) and Safety and tolerability of levetiracetam XR. Started May 2006; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-000987-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000987-10.